Evaluation of in-study cut points to enable appropriate interpretation of clinical immunogenicity results
- 1 September 2019
- journal article
- editorial
- Published by Future Science Ltd in Bioanalysis
- Vol. 11 (17), 1539-1541
- https://doi.org/10.4155/bio-2019-0110
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Statistical Evaluation of Several Methods for Cut-Point Determination of Immunogenicity Screening AssayJournal of Biopharmaceutical Statistics, 2014
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsJournal of Immunological Methods, 2008
- A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugsNature Biotechnology, 2007
- Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsJournal of Immunological Methods, 2004